IPH — Innate Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Innate Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	152	120	101	92.5	80.8
Net Total Accounts Receivable
Net Total Receivables	13.9	13.5	31	55.6	4.97
Prepaid Expenses
Total Current Assets	173	138	140	148	85.7
Net Property, Plant And Equipment	11.7	10.2	8.54	6.32	5.13
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	307	267	208	175	111
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.5	79.9	41.3	39.6	33
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	151	160	154	123	102
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	156	107	54.2	51.9	8.83
Total Liabilities & Shareholders' Equity	307	267	208	175	111
Total Common Shares Outstanding
Total Preferred Shares Outstanding